ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2026
Improving public health laboratory preparedness at European Union level: learning points from experiences during the COVID-19 pandemic.
Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This Perspective discusses how European Union (EU)-level action could support public health laboratories in preparing for future threats from respiratory infectious diseases. It draws extensively from a study that looked at the experience of public health laboratories in EU/ European Economic Area (EEA) countries during the COVID-19 pandemic. This study included a literature review and consultation with stakeholders from public health laboratories in EU/EEA countries and from EU institutions. We discuss how to address the challenges faced by public health laboratories during the COVID-19 pandemic, focusing particularly on the role of EU institutions. The Perspective concludes by discussing the importance of improving public health laboratory preparedness for future health threats when there is no ongoing public health emergency, instead of during a health emergency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.